RANKINGS

Highest ROE — Healthcare

Return on Equity measures how efficiently a company generates profit from shareholder equity.

181 companies with ROE data.

Ranked by ROE(181)

#	Ticker	Name	Industry	Market Cap	ROE
1	CLX	CLOROX CO /DE/ TTM · 2026-03-31 Analysis WACC DCF	Other	$10.1B	821.7%
2	CL	COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$70.4B	360.1%
3	HALO	HALOZYME THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$12.5B	288.1%
4	TRAW	Traws Pharma, Inc. TTM · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$7M	139.8%
5	ZTS	Zoetis Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$30.9B	83.1%
6	RIGL	RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$917M	75.7%
7	AMGN	Amgen Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$224.3B	74.8%
8	TGTX	TG THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$8.5B	73.1%
9	IDXX	IDEXX LABORATORIES INC /DE TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$40.8B	70.7%
10	LLY	ELI LILLY AND COMPANY FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.1T	60.9%
11	ALNY	ALNYLAM PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$31.1B	59.7%
12	ABEO	ABEONA THERAPEUTICS INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$282M	55.6%
13	EXEL	Exelixis Inc TTM · 2026-07-03 Analysis WACC DCF	Pharmaceuticals	$14.8B	46.7%
14	BMY	BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$120.8B	41.6%
15	WDFC	WD-40 COMPANY TTM · 2026-05-31 Analysis WACC DCF	Other	$2.7B	32.0%
16	JNJ	Johnson & Johnson FY · 2025-12-28 Analysis WACC DCF	Pharmaceuticals	$630.0B	31.5%
17	PG	PROCTER & GAMBLE CO FY · 2026-06-30 Analysis WACC DCF	Other	$351.3B	29.5%
18	FTK	FLOTEK INDUSTRIES INC/CN TTM · 2026-06-30 Analysis WACC DCF	Other	$970M	29.4%
19	ACAD	ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$3.4B	29.1%
20	CF	CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$16.9B	28.0%
21	PLX	PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$224M	26.5%
22	PAHC	Phibro Animal Health Corporation FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.6B	25.9%
23	INVA	INNOVIVA, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.5B	22.0%
24	NNNN	Anbio Biotechnology FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$205M	21.2%
25	UG	UNITED-GUARDIAN, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$32M	21.2%
26	LNTH	LANTHEUS HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$6.5B	21.0%
27	ECL	ECOLAB INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$79.0B	21.0%
28	UTHR	United Therapeutics Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$23.6B	20.5%
29	LGND	LIGAND PHARMACEUTICALS INCORPORATED TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$6.0B	20.4%
30	ORMP	ORAMED PHARMACEUTICALS INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$180M	20.2%
31	RPM	RPM International Inc. TTM · 2026-08-31 Analysis WACC DCF	Other	$12.5B	19.8%
32	JAZZ	Jazz Pharmaceuticals plc TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$14.2B	19.6%
33	VRTX	VERTEX PHARMACEUTICALS INC / MA FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$129.3B	19.5%
34	NAGE	NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$213M	19.4%
35	PPG	PPG INDUSTRIES INC TTM · 2026-03-31 Analysis WACC DCF	Other	$23.1B	19.2%
36	REX	REX AMERICAN RESOURCES CORPORATION TTM · 2026-07-31 Analysis WACC DCF	Other	$1.4B	19.2%
37	NBIX	NEUROCRINE BIOSCIENCES, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$14.5B	19.1%
38	TEVA	TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$47.9B	18.2%
39	ANIP	ANI PHARMACEUTICALS, INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	18.1%
40	LIN	Linde plc TTM · 2026-06-30 Analysis WACC DCF	Other	$223.0B	17.8%
41	SOLS	Solstice Advanced Materials Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$9.7B	17.2%
42	CHD	CHURCH & DWIGHT CO., INC. FY · 2025-12-31 Analysis WACC DCF	Other	$23.3B	16.9%
43	KVUE	Kenvue Inc. TTM · 2026-06-28 Analysis WACC DCF	Other	$34.0B	15.7%
44	IPAR	INTERPARFUMS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$3.6B	15.4%
45	LFVN	LIFEVANTAGE CORP FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$76M	15.1%
46	REGN	REGENERON PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$76.9B	13.7%
47	FTLF	FITLIFE BRANDS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$86M	13.2%
48	BCPC	Balchem Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$5.4B	12.6%
49	SXT	Sensient Technologies Corp TTM · 2026-06-30 Analysis WACC DCF	Other	$5.5B	12.5%
50	ABT	ABBOTT LABORATORIES TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$172.3B	11.9%
51	CBT	Cabot Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$3.9B	11.0%
52	NATR	NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$222M	10.7%
53	FUL	FULLER H B CO TTM · 2026-08-29 Analysis WACC DCF	Other	$2.7B	9.1%
54	HXL	Hexcel Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$6.4B	9.0%
55	IOSP	INNOSPEC INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2.4B	8.6%
56	TECH	BIO-TECHNE Corp FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11.4B	8.6%
57	CORT	CORCEPT THERAPEUTICS INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$13.1B	7.8%
58	MRK	Merck & Co., Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$359.2B	7.6%
59	BIIB	BIOGEN INC. TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$33.3B	7.4%
60	EMN	EASTMAN CHEMICAL CO TTM · 2026-06-30 Analysis WACC DCF	Other	$7.2B	7.2%
61	GYRE	Gyre Therapeutics, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$746M	6.9%
62	LXU	LSB Industries, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$706M	6.8%
63	CRON	CRONOS GROUP INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.2B	6.3%
64	ALTO	ALTO INGREDIENTS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$289M	5.1%
65	PFE	PFIZER INC TTM · 2026-06-28 Analysis WACC DCF	Pharmaceuticals	$161.2B	5.1%
66	EL	Estee Lauder Companies Inc FY · 2026-06-30 Analysis WACC DCF	Other	$35.5B	4.8%
67	VCEL	VERICEL CORPORATION FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2.1B	4.5%
68	SCL	STEPAN COMPANY FY · 2025-12-31 Analysis WACC DCF	Other	$1.4B	3.9%
69	AVNT	AVIENT CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$3.5B	3.3%
70	LXFR	LUXFER HOLDINGS PLC TTM · 2026-03-29 Analysis WACC DCF	Other	$465M	2.6%
71	ALB	ALBEMARLE CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$12.0B	2.1%
72	RGEN	REPLIGEN CORP TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11.0B	2.0%
73	IFF	INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 Analysis WACC DCF	Other	$21.6B	1.9%
74	BMRN	BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$10.6B	1.2%
75	DD	DUPONT DE NEMOURS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$17.6B	0.4%
76	ACB	AURORA CANNABIS INC FY · 2025-03-31 Analysis WACC DCF	Pharmaceuticals	$284M	0.3%
77	APD	AIR PRODUCTS AND CHEMICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$62.6B	-0.3%
78	NEOG	Neogen Corporation FY · 2026-05-31 Analysis WACC DCF	Biotechnology	$2.6B	-0.4%
79	SNDL	SNDL Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$300M	-1.4%
80	SIGA	Siga Technologies INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$236M	-1.7%
81	NEUP	Neuphoria Therapeutics Inc. FY · 2025-06-30 Analysis WACC DCF	Pharmaceuticals	$18M	-1.9%
82	TXMD	TherapeuticsMD, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$24M	-2.1%
83	VTRS	VIATRIS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$20.3B	-2.9%
84	LYB	LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 Analysis WACC DCF	Other	$19.4B	-3.2%
85	ICCC	ImmuCell Corporation FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$89M	-3.3%
86	BON	BON NATURAL LIFE LIMITED FY · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$9M	-3.4%
87	VHI	VALHI, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$402M	-3.7%
88	USNA	USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 Analysis WACC DCF	Pharmaceuticals	$271M	-3.9%
89	MTX	MINERALS TECHNOLOGIES INC. TTM · 2026-07-05 Analysis WACC DCF	Other	$2.0B	-4.3%
90	ROG	ROGERS CORP TTM · 2026-03-31 Analysis WACC DCF	Other	$2.6B	-4.7%
91	MOS	MOSAIC CO TTM · 2026-06-30 Analysis WACC DCF	Other	$6.0B	-5.5%
92	ACNT	Ascent Industries Co. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$122M	-5.6%
93	OPK	OPKO Health, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.0B	-6.2%
94	EPC	EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$1.3B	-6.4%
95	NL	NLI HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$339M	-6.7%
96	CYRX	CRYOPORT, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$879M	-6.9%
97	TLRY	Tilray Brands, Inc. FY · 2026-05-31 Analysis WACC DCF	Pharmaceuticals	$523M	-7.6%
98	FSI	FLEXIBLE SOLUTIONS INTERNATIONAL INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$77M	-7.6%
99	LTBR	LIGHTBRIDGE CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$214M	-8.2%
100	AMRN	AMARIN CORP PLC\UK FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$254M	-8.7%